22. STUDY ON THE PREVALENCE OF HIV INFECTION AND CO-INFECTION WITH HBV AND HCV AMONG INDIVIDUALS TESTED FOR HIV AT MILITARY HOSPITAL 103 FROM JANUARY 2017 TO DECEMBER 2023

Nguyen Hung Cuong1, Nguyen Le Van1, Nguyen Duc Hai2, Tran Nguyen Vu Ha2, Nguyen Van An1
1 Military Hospital 103
2 Vietnam Military Medical Academy

Main Article Content

Abstract

Objective: To determine the prevalence of HIV (Human immunodeficiency virus) infection and co-infection with HBV (Hepatitis B virus) and/or HCV (Hepatitis C virus) in HIV-positive patients examined and treated at Military Hospital 103 from January 2017 to December 2023.


Subjects and Methods: A cross-sectional descriptive study was conducted on patients who were tested for HIV during the period from January 2017 to December 2023.


Results: The average HIV infection rate among patients tested at Military Hospital 103 was 0.21%. HIV infection was most common in 30 - 39 age group, accounting for 35.38%, and least common in individuals aged ≤ 19 (3.59%). The male-to-female ratio was 2.8:1. Among HIV-infected individuals, the prevalence of co-infection with HBV and/or HCV is 38.21%. Specifically, 25.13% are co-infected with HCV, 11.03% with HBV, and 2.05% are co-infected with both HBV and HCV.


Conclusion: This study conducted at Military Hospital 103 from January 2017 to December 2023 showed an HIV detection rate among tested patients was 0.21%. The proportion of HIV infection was high in the 30 - 39 years and male individuals. The rate of HIV patients co-infected with HBV and/or HCV is relatively high (38.21%).

Article Details

References

[1] UNAIDS (2023), Global HIV statistic
[2] Bộ Y tế (2024), Tình hình và kết quả công tác phòng, chống HIV/AIDS năm 2023, Phòng, chống HIV/AIDS 2024, Quyết định số 612/QĐ-BYT.
[3] WHO (2016), Sustainable development goals (‎SDGs)‎ : Goal 3.
[4] M. Ganesan, L. Poluektova, K. Kharbanda et.al. (2019), Human immunodeficiency virus and hepatotropic viruses comorbidities as the inducers of liver injury progression, World J. Gastroenterol, p. 398–410.
[5] Bộ Y tế (2024), Hướng dẫn Quốc gia xét nghiệm HIV, Quyết định số 2674/QĐ-BYT.
[6] Vũ Thị Bắc (2012), Nghiên cứu tỷ lệ nhiễm HIV trên các đối tượng đến khám bệnh tại Trung tâm cấp cứu 115 từ 1/2010 đến 6/2012, Luận văn Thạc sỹ Y học, Học viện Quân y.
[7] Cục phòng chống HIV/AIDS – Bộ Y tế (2022), Định hướng năm 2023 và những năm tiếp theo: Hướng tới chấm dứt dịch bệnh AIDS vào năm 2030, 8/12/2022.
[8] Đỗ Huy Cường (2015), Tỷ lệ đồng nhiễm HBV, HCV trên các bệnh nhân HIV và một số yếu tố liên quan tại Khoa Truyền nhiễm, bệnh viện Bạch Mai, Tạp chí Y học Dự phòng, Tập XXV, số số 6 (166) , p. 276.
[9] Riddhi Pradhan, Kirti Hemwani, Vidit Khandelwal, et.al. (2023), A cross-sectional study on co-infection of hepatitis B and hepatitis C among people living with HIV/AIDS from a tertiary care hospital of Central India, Asian Journal of Medical Sciences, vol. 14, no. 4, pp. 61-67.
[10] L. B. Shrestha (2022), Co-infection of Hepatitis B and Hepatitis C among HIV-infected patients: A cross-sectional study from tertiary care hospital of eastern Nepal, PLOS ONE, vol. 17, no. 3.